Venture-Backed Startups
127,716 companies with verified investor relationships.
Cadrenal Therapeutics is a clinical-stage biopharmaceutical company developing anticoagulation and antithrombotic therapies for cardiovascular and thrombotic disorders. Its pipeline includes CAD-1005, a first-in-class 12-LOX inhibitor for heparin-induced thrombocytopenia, tecarfarin for end-stage kidney disease and LVAD patients, and frunexian, an intravenous Factor XIa inhibitor for acute/critical care settings.</parameter> <parameter name="founders">[]
0 investors
Cadrian AI runs large-scale automated interviews with a company's employees to map workflows, surface operational bottlenecks, and identify where AI can deliver ROI. It serves companies seeking an AI audit or an understanding of how work actually flows across teams, positioned as an alternative to consultants and surveys.
1 investor
Cadro is an investment management firm that combines technology with personalised service and investment expertise to serve modern individual investors.
2 investors
CADshare turns manufacturers' existing CAD design data into interactive 3D parts manuals and a cloud-based platform for remote aftermarket sales, spare parts e-commerce, and support. It serves equipment and machinery makers looking to manage aftersales ordering, analytics, and customer service.
1 investor
Cadstrom provides automated schematic and PCB validation software that catches design errors traditional ERC flows and manual reviews miss, producing structured validation reports before boards go to fabrication. It serves hardware and electrical engineering teams looking to reduce respins, project cost, and schedule delays.
2 investors
CADY provides AI-powered schematic analysis that reviews Netlist and BOM files to detect design flaws, errors, and best-practice violations in high-density PCB designs within minutes. It is aimed at hardware and electronics engineering teams working on complex circuit board designs.
5 investors
0 investors
Caedo Oncology develops cancer immunotherapies, including CO-1, a bifunctional anti-CD47 monoclonal antibody that blocks SIRPα–CD47 interactions and induces programmed cell death of cancer cells. The company targets improved treatment options for cancer patients.
2 investors
Caeli AI is a shopping assistant that identifies products eligible for HSA/FSA benefits, pays using benefit cards or automates reimbursement, and obtains clinician-approved Letters of Medical Necessity at checkout. It targets consumers who want to use tax-advantaged health accounts on everyday wellness and medical products.
1 investor
Next-generation energy-efficient, low-carbon air conditioners.
3 investors
Caeli Nova, founded in 2018, develops physiological monitoring technology for fast jet aircrew that aims to improve safety, optimize performance, and reduce operational downtime, drawing on respiratory physiology, medical research, and aerospace engineering. Its roadmap extends to broader military personnel and other sectors where human performance is critical.
1 investor
Caeli Vascular develops a medical device platform for the treatment of venous thrombotic disease, specifically designed to remove blood clots in deep vein thrombosis cases. The company targets physicians and healthcare institutions seeking to improve patient outcomes in interventional vascular care.
1 investor
Caeli Wind operates a marketplace that connects German landowners — including industrial businesses and investors — with wind farm project developers, running feasibility and site analyses, tenders, and legal/permitting support to lease land for wind energy. It offers free site assessments and manages the full leasing process for property owners across Germany.
1 investor
0 investors
Caelum Health develops software-based treatments for chronic digestive conditions including IBS, combining clinical data, medical expertise, and personalized coaching delivered through a digital platform.
1 investor
Caelus is a chip design company that develops high-performance ADC/DAC integrated circuits, including high-precision SAR ADCs and high-speed ADCs, using its own patented technology. Its products serve industries such as industrial automation, energy, instrumentation and measurement, data acquisition, communications, and medical imaging.
3 investors
Caelux develops perovskite-based solar technology and manufactures Active Glass solutions to improve solar energy efficiency, power output, and cost-effectiveness using advanced manufacturing and machine learning.
3 investors
CAEmate develops WeStatiX SHM, a cloud-based platform for predictive maintenance of civil infrastructure using structural health monitoring and digital twins with AI. The solution serves infrastructure operators and asset managers to improve safety and reduce maintenance costs.
2 investors
0 investors
0 investors
0 investors
Caesarea Labs develops electronic design automation (EDA) and manufacturing execution systems (MES) tools to accelerate post-silicon validation testing in semiconductor chip development. The company serves semiconductor manufacturers looking to reduce test design time, improve process visibility, and lower validation costs.
1 investor
0 investors
0 investors